GlycoMimetics (NASDAQ: GLYC) reported Q1 EPS of ($0.28), $0.03 better than the analyst estimate of ($0.31). Cash and cash equivalents at March 31, 2022 were $76.5 million.

For earnings history and earnings-related data on GlycoMimetics (GLYC) click here.